NDC Code(s) : 25021-109-10, 25021-110-20
Packager : Sagent Pharmaceuticals

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

Cefoxitincefoxitin INJECTION, POWDER, FOR SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:25021-109
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
cefoxitin sodium(UNII: Q68050H03T)
(cefoxitin - UNII:6OEV9DX57Y) 		cefoxitin1 g
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:25021-109-1010 in 1 CARTON 11/05/2009
11 in 1 VIAL Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA065414 11/05/2009
Cefoxitincefoxitin INJECTION, POWDER, FOR SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:25021-110
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
cefoxitin sodium(UNII: Q68050H03T)
(cefoxitin - UNII:6OEV9DX57Y) 		cefoxitin2 g
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:25021-110-2010 in 1 CARTON 11/05/2009
11 in 1 VIAL Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA065414 11/05/2009

LABELER - Sagent Pharmaceuticals(080579617)

PRINCIPAL DISPLAY PANEL

NDC 25021-109-10

Rx only

CEFOXITIN for Injection, USP

1 gram per vial

For Intravenous Use Only

Single-Dose Vial

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label

PRINCIPAL DISPLAY PANEL

NDC 25021-110-20

Rx only

Cefoxitin for Injection, USP

2 grams per vial

For Intravenous Use Only

Single-Dose Vial

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label